Whereas 2D-EVs led to a decline in K10 expression and formation of sporadic aggregates of K5 versus the more homogenous cellular distribution seen in 3D-EV treated KC, possibly hinting at enhanced K5 protein turnover and remodeling occurring in 2D-EV treated KCs. The gene discussed is KRT10; the disease is keratoconus.